18 March 2022
R&A intervened on M Capital’s exit from Nightshift Group (PDF)
22 January 2022
R&A advises Dogamí on its fundraising with Ubisoft, Animoca Brands and XAnge. (PDF)
18 January 2022
R&A advised Enalees on the sale of its human health business to Biosynex (Euronext Paris). (PDF)
15 November 2021
Reboul & Associés advise Bridge.Audio on its BSA Air issue. (PDF)
18 October 2021
Reboul & Associés advise Dassault Systèmes (Euronext Paris) on its investment in Bloom alongside Habert Dassault Finance and Swisscom. (PDF)
5 October 2021
Reboul & Associés advises on the acquisition of Biosantis by BIOGROUP, the second largest European medical biology group. (PDF)
2 August 2021
Reboul & Associés advise Dassault Systèmes (Euronext Paris) on the acquisition of Iterop.
14 June 2021
Reboul & Associés advises Fineheart on its 15 MEUR Series B. (PDF)
31 March 2021
Reboul & Associés advises Creaminal in its merger with Alter K (PDF)
29 January 2021
